The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,616,619 in first-year total cost, median $216,358.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MDCN-B (55)]17
Most frequent institutions
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH3
- OLD DOMINION UNIVERSITY2
- UNIVERSITY OF MISSOURI-COLUMBIA2
- CHILDREN'S HOSP OF PHILADELPHIA1
- GENEVA FOUNDATION1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Antidotes against mustard-induced chronic lung injury1R21ES030528-01 | CATRAVAS, JOHN D | OLD DOMINION UNIVERSITY, VA | $232,500 | ZRG1 |
| 2018 | Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard1R21EY030234-01 | MOHAN, RAJIV RAVINDRA | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $232,500 | ZRG1 |
| 2018 | Nanomedicine Approach to Counteract Acrolien-induced Blindness and Toxicity to the Eye1R21EY030233-01A1 | CHAURASIA, SHYAM SUNDERGIULIANO, ELIZABETHMOHAN, RAJIV RAVINDRA | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $231,950 | ZRG1 |
| 2018 | Identification of novel brain-penetrating oxime antidotes for phorate toxicity1R21NS108954-01 | CHAMBERS, JANICE ELAINE | MISSISSIPPI STATE UNIVERSITY, MS | $215,635 | ZRG1 |
| 2017 | An Approach toward Antidotes for Phosphine1R21ES029310-01 | PEARCE, LINDA LPETERSON, JAMES | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $233,500 | ZRG1 |
| 2017 | Antidotes against Hydrochloric Acid-Induced Chronic Lung Injury1R21ES029309-01 | CATRAVAS, JOHN D | OLD DOMINION UNIVERSITY, VA | $232,500 | ZRG1 |
| 2017 | Epigenetic Attenuation of Long-Term Effects of Nerve Agents1R21NS099009-01A1 | REDDY, DOODIPALA SAMBA | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $222,750 | ZRG1 |
| 2017 | Toxin-specific and symptomatic drugs in combination with novel neuroprotectants effectively counteract DFP-induced long-term neurotoxicity1R21NS099007-01A1 | THIPPESWAMY, THIMMASETTAPPA | IOWA STATE UNIVERSITY, IA | $216,358 | ZRG1 |
| 2017 | Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats1R21NS103826-01 | KILBAUGH, TODD JUSTEN | CHILDREN'S HOSP OF PHILADELPHIA, PA | $215,000 | ZRG1 |
| 2017 | Phosgene Oxime Cutaneous Toxicity and Mechanisms to Identify Therapeutic Targets1R21AR073544-01 | TEWARI-SINGH, NEERA | UNIVERSITY OF COLORADO DENVER, CO | $213,825 | ZRG1 |
| 2017 | The carboxylesterase knockout mouse as a model to evaluate the efficacy of delayed medical countermeasures against soman exposure1R21NS103820-01 | LANGE, LUCILLE | GENEVA FOUNDATION, WA | $179,700 | ZRG1 |
| 2017 | Computationally Designed Stable Artificial Phosphotriesterases for Detoxification of Organophosphorus Agents1R21NS103831-01 | MONTCLARE, JIN KIM | NEW YORK UNIVERSITY, NY | $162,749 | ZRG1 |
| 2016 | Effects of acute administration of the Phenothiazinium Chromophore Methylene blue during life threatening cyanide intoxication1R21NS098991-01 | HAOUZI, PHILIPPE A | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $247,195 | ZRG1 |
| 2016 | Countermeasure Therapeutics for Acute Lung Injury1R21ES027390-01 | LEIKAUF, GEORGE DOUGLASTEJERO BRAVO, JESUS | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $231,375 | ZRG1 |
| 2016 | Treatment of persistent chlorine-induced small airway disease1R21ES027391-01 | HOYLE, GARY W. | UNIVERSITY OF LOUISVILLE, KY | $201,270 | ZRG1 |
| 2016 | New Chelating (decorporating) Agents for Azide1R21NS098989-01 | PEARCE, LINDA LPETERSON, JAMES | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $192,812 | ZRG1 |
| 2016 | Overlay independent X-ray data analysis for enhanced oxime OP-ChE reactivation1R21NS098998-01 | RADIC, ZORAN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $155,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.